Skip to content
DraconiticResearch
Search Sources API
220,616 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0Journal of Clinical Medicine

Serum suPAR Associations with Clinical and Laboratory Variables and Emergency Department Disposition in Adults with Respiratory Symptoms: A Prospective Observational Cohort Study

5 affiliations
  1. 1Laboratory of Human Pathophysiology, Department of Nursing, University of Thessaly, Gaiopolis, 41500 Larissa, Greece
  2. 2Pulmonology Department, General Hospital of Corfu, 491 00 Corfu, Greece
  3. 3Laboratory of Respiratory Disorders, Department of Nursing, University of Thessaly, Gaiopolis, 41500 Larissa, Greece
  4. 4Department of Respiratory Medicine, University of Thessaly, Biopolis, 41110 Larissa, Greece
  5. 5Public Health and Adults Immunization Laboratory, Department of Nursing, University of Thessaly, Gaiopolis, 41500 Larissa, Greece

Abstract

Background: Soluble urokinase plasminogen activator receptor (suPAR) reflects systemic immune activation. We examined associations between serum suPAR and pulmonary/internal-medicine admission in adults presenting to the emergency department (ED) with respiratory symptoms. Methods: This prospective single-centre exploratory pilot included 87 adults (54 pathway admissions; 33 ED discharges). Serum suPAR concentrations were determined using four-parameter logistic calibration of an eight-point ELISA standard curve, with correction for the fivefold serum dilution. Exploratory adjusted logistic regression and single-marker ROC analyses were performed. Results: Median serum suPAR was 3440.0 (2497.5–4535.0) pg/mL overall, 3955.0 (2979.0–5559.0) pg/mL among admitted patients and 2832.5 (2216.0–3317.5) pg/mL among discharged patients (p < 0.001). The apparent AUC for suPAR was 0.765 (95% bootstrap CI 0.663–0.856). After adjustment for age-category midpoint, sex, SpO2 and log-CRP, the odds ratio for admission per 1-SD increase in log-suPAR was 2.43 (95% CI 1.18–4.98; p = 0.015); the corresponding estimate for log-CRP was 1.69 (0.93–3.07; p = 0.084). Conclusions: Serum suPAR was associated with pathway-specific admission after adjustment for CRP and selected clinical covariates. These exploratory findings do not establish incremental clinical utility and require external validation.

Related

  1. Reduced Circulating Regulatory T Cells in Autoimmune and Chronic Idiopathic Neutropenia of Childhood: An Observational Study of Clinical and Laboratory Associations
    Konstantina Toutoudaki, Elena E. Solomou, Marianna Tzanoudaki +10
    European Journal of HaematologyPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  2. Day 3 blood urea nitrogen and discharge disposition in patients with pleural infection: a multicenter prospective study
    Takamasa Hotta, Tamio Okimoto, Masayuki Ishida +12
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Associations of self−directed learning ability and critical thinking disposition with internship performance indicators in nursing interns
    Caixia Dai, Yongbao Wei, Yuxuan Liang +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
  4. Viral etiology and predictors of hospitalization in adults younger than 65 years with laboratory-confirmed respiratory viral infections in the pre-COVID era
    Benjamin Davido, Djillali Annane, Michelle Saliba +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  5. The diagnostic role of SARS-CoV-2 in routine respiratory testing after policy adjustment: a real-world laboratory study integrating longitudinal PCR and respiratory pathogen testing workflow data.
    Jian-Min Ren, Xiao-Yao Zhang, Xiao-Peng Liu +6
    BMC infectious diseasesPeer-reviewedCC BY-NC-NDFull textInfectious diseaseEurope PMCPMC
BibTeX
@article{karpouza2026serum,
  title = {{Serum suPAR Associations with Clinical and Laboratory Variables and Emergency Department Disposition in Adults with Respiratory Symptoms: A Prospective Observational Cohort Study}},
  author = {Anna Karpouza and Paraskevi Kirgou and Vasiliki Sachtaridou and Dimitrios Papagiannis and Erasmia Rouka and Foteini Malli and Ioannis Pantazopoulos and Ilias Papanikolaou and Ourania S. Kotsiou},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  month = nov,
  doi = {10.3390/jcm15228857},
  url = {https://www.mdpi.com/2077-0383/15/22/8857},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Serum suPAR Associations with Clinical and Laboratory Variables and Emergency Department Disposition in Adults with Respiratory Symptoms: A Prospective Observational Cohort Study
AU  - Anna Karpouza
AU  - Paraskevi Kirgou
AU  - Vasiliki Sachtaridou
AU  - Dimitrios Papagiannis
AU  - Erasmia Rouka
AU  - Foteini Malli
AU  - Ioannis Pantazopoulos
AU  - Ilias Papanikolaou
AU  - Ourania S. Kotsiou
PY  - 2026
DA  - 2026/11/12
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15228857
UR  - https://www.mdpi.com/2077-0383/15/22/8857
AB  - Background: Soluble urokinase plasminogen activator receptor (suPAR) reflects systemic immune activation. We examined associations between serum suPAR and pulmonary/internal-medicine admission in adults presenting to the emergency department (ED) with respiratory symptoms. Methods: This prospective single-centre exploratory pilot included 87 adults (54 pathway admissions; 33 ED discharges). Serum suPAR concentrations were determined using four-parameter logistic calibration of an eight-point ELISA standard curve, with correction for the fivefold serum dilution. Exploratory adjusted logistic regression and single-marker ROC analyses were performed. Results: Median serum suPAR was 3440.0 (2497.5–4535.0) pg/mL overall, 3955.0 (2979.0–5559.0) pg/mL among admitted patients and 2832.5 (2216.0–3317.5) pg/mL among discharged patients (p < 0.001). The apparent AUC for suPAR was 0.765 (95% bootstrap CI 0.663–0.856). After adjustment for age-category midpoint, sex, SpO2 and log-CRP, the odds ratio for admission per 1-SD increase in log-suPAR was 2.43 (95% CI 1.18–4.98; p = 0.015); the corresponding estimate for log-CRP was 1.69 (0.93–3.07; p = 0.084). Conclusions: Serum suPAR was associated with pathway-specific admission after adjustment for CRP and selected clinical covariates. These exploratory findings do not establish incremental clinical utility and require external validation.
SN  - 2077-0383
ER  -